Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.83 USD | +5.99% | +4.43% | +21.46% |
May. 09 | Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q1 Revenue $98,000 | MT |
May. 09 | VYNE Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.46% | 39.9M | |
+29.98% | 682B | |
+31.73% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.36% | 240B | |
+9.36% | 209B | |
-8.83% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- VYNE Therapeutics : Barclays Adjusts Price Target for VYNE Therapeutics to $15 From $12, Maintains Overweight Rating